Paracrine signalling of AGR2 stimulates RhoA function in fibroblasts and modulates cell elongation and migration

References

• Ungefroren H, Sebens S, Seidl D, et al. Interaction of tumor cells with the microenvironment. Cell Commun Signal. 2011 Sep;13(9):18.
   Google Scholar
• Lee SW, Kwak HS, Kang MH, et al. Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid. Sci Rep. 2018 Feb 5;8(1):2365.
   PubMedGoogle Scholar
• Wong T, McGrath JA, Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol. 2007 Jun;156(6):1149–1155.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006 May;6(5):392–401.
   PubMed Web of Science ®Google Scholar
• Sadlonova A, Novak Z, Johnson MR, et al. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res. 2005;7(1):R46–59.
   PubMed Web of Science ®Google Scholar
• Cohen N, Shani O, Raz Y, et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017 Aug;36(31):4457–4468.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012 Mar 20;21(3):309–322.
   PubMed Web of Science ®Google Scholar
• Guo H, Chen H, Zhu Q, et al. A humanized monoclonal antibody targeting secreted anterior gradient 2 effectively inhibits the xenograft tumor growth. Biochem Biophys Res Commun. 2016 Jun 17;475(1):57–63.
   PubMed Web of Science ®Google Scholar
• Hong XY, Wang J, Li Z. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma. Cell Biochem Biophys. 2013;67(3):1487–1495.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Satoyoshi R, Aiba N, et al. Agr2 mediates paracrine effects on stromal fibroblasts that promote invasion by gastric signet-ring carcinoma cells. Cancer Res. 2015 Jan 15;75(2):356–366.
   PubMed Web of Science ®Google Scholar
• Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol. 2005 Oct;15(5):329–341.
   PubMed Web of Science ®Google Scholar
• Iacopino F, Angelucci C, Sica G. Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system. Anticancer Res. 2012 May;32(5):1579–1588.
   PubMed Web of Science ®Google Scholar
• Delom F, Nazaraliyev A, Fessart D. The role of protein disulphide isomerase AGR2 in the tumour niche. Biol Cell. 2018 Dec;110(12):271–282.
   PubMed Web of Science ®Google Scholar
• Aberger F, Weidinger G, Grunz H, et al. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev. 1998 Mar;72(1–2):115–130.
   PubMed Web of Science ®Google Scholar
• Kumar A, Godwin JW, Gates PB, et al. Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science. 2007 Nov 2;318(5851):772–777.
   PubMed Web of Science ®Google Scholar
• Guo H, Zhu Q, Yu X, et al. Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization. Oncogene. 2017 Sep 7;36(36):5098–5109.
   PubMed Web of Science ®Google Scholar
• Salmans ML, Zhao F, Andersen B. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res. 2013 Apr 24;15(2):204.
   PubMed Web of Science ®Google Scholar
• Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, et al. Fibroblasts in the tumor microenvironment: shield or spear? Int J Mol Sci. 2018 May 21;19(5):1532.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Mangukiya HB, Mashausi DS, et al. Anterior gradient 2 is induced in cutaneous wound and promotes wound healing through its adhesion domain. Febs J. 2017 Sep;284(17):2856–2869.
   PubMed Web of Science ®Google Scholar
• Smirnov DA, Zweitzig DR, Foulk BW, et al. Global gene expression profiling of circulating tumor cells. Cancer Res. 2005 Jun 15;65(12):4993–4997.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hao Y, Lowe AW. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008 Jan 15;68(2):492–497.
   PubMed Web of Science ®Google Scholar
• Chevet E, Fessart D, Delom F, et al. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene. 2013 May 16;32(20):2499–2509.
   PubMed Web of Science ®Google Scholar
• Brychtova V, Mohtar A, Vojtesek B, et al. Mechanisms of anterior gradient-2 regulation and function in cancer. Semin Cancer Biol. 2015;33:16–24.
   PubMed Web of Science ®Google Scholar
• Higa A, Mulot A, Delom F, et al. Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. J Biol Chem. 2011 Dec 30;286(52):44855–44868.
   PubMed Web of Science ®Google Scholar
• Negi H, Merugu SB, Mangukiya HB, et al. Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: a preclinical study. Cancer Lett. 2019 May 1;449:125–134.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim DH, Kang D, et al. Expression of anterior gradient 2 is decreased with the progression of human biliary tract cancer. Tohoku J Exp Med. 2014 Sep;234(1):83–88.
   PubMed Web of Science ®Google Scholar
• Di Maro G, Salerno P, Unger K, et al. Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells. Mol Cancer. 2014 Jun 30;13:160.
   PubMed Web of Science ®Google Scholar
• Huang J, Wang L, Jiang M, et al. AGR2-mediated lung adenocarcinoma metastasis novel mechanism network through repression with interferon coupling cytoskeleton to steroid metabolism-dependent humoral immune response. Cel Immunol. 2014 Jul;290(1):102–106.
   PubMed Web of Science ®Google Scholar
• Pohler E, Craig AL, Cotton J, et al. The Barrett’s antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cel Proteomics. 2004 Jun;3(6):534–547.
   PubMed Web of Science ®Google Scholar
• Willis S, Villalobos VM, Gevaert O, et al. Single gene prognostic biomarkers in ovarian cancer: a meta-analysis. PloS One. 2016;11(2):e0149183.
   PubMed Web of Science ®Google Scholar
• Haviv I, Polyak K, Qiu W, et al. Origin of carcinoma associated fibroblasts. Cell Cycle. 2009 Feb 15;8(4):589–595.
   PubMed Web of Science ®Google Scholar
• Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004 Nov;4(11):839–849.
   PubMed Web of Science ®Google Scholar
• Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth–bystanders turning into key players. Curr Opin Genet Dev. 2009 Feb;19(1):67–73.
   PubMed Web of Science ®Google Scholar
• Rama-Esendagli D, Esendagli G, Yilmaz G, et al. Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer. Mol Biol Rep. 2014 May;41(5):2885–2892.
   PubMed Web of Science ®Google Scholar
• Saito RA, Micke P, Paulsson J, et al. Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. Cancer Res. 2010 Apr 1;70(7):2644–2654.
   PubMed Web of Science ®Google Scholar
• Thoma CR, Stroebel S, Rosch N, et al. A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications. J Biomol Screen. 2013 Dec;18(10):1330–1337.
   PubMedGoogle Scholar
• Thoma CR, Zimmermann M, Agarkova I, et al. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev. 2014;69–70:29–41.
   PubMed Web of Science ®Google Scholar
• Ahn SM, Simpson RJ. Body fluid proteomics: prospects for biomarker discovery. Proteomics Clin Appl. 2007 Sep;1(9):1004–1015.
   PubMed Web of Science ®Google Scholar
• Haslene-Hox H, Madani A, Berg KC, et al. Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood. BBA Clin. 2014;2:18–23.
   PubMedGoogle Scholar
• Karsdal MA, Nielsen MJ, Sand JM, et al. Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol. 2013 Mar;11(2):70–92.
   PubMed Web of Science ®Google Scholar
• Kraning-Rush CM, Reinhart-King CA. Controlling matrix stiffness and topography for the study of tumor cell migration. Cell Adh Migr. 2012 May–Jun;6(3):274–279.
   PubMed Web of Science ®Google Scholar
• Wolf K, Friedl P. Extracellular matrix determinants of proteolytic and non-proteolytic cell migration. Trends Cell Biol. 2011 Dec;21(12):736–744.
   PubMed Web of Science ®Google Scholar
• Flach EH, Rebecca VW, Herlyn M, et al. Fibroblasts contribute to melanoma tumor growth and drug resistance. Mol Pharm. 2011 Dec 5;8(6):2039–2049.
   PubMedGoogle Scholar
• Imamura Y, Mukohara T, Shimono Y, et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol Rep. 2015 Apr;33(4):1837–1843.
   PubMed Web of Science ®Google Scholar
• Patra B, Peng CC, Liao WH, et al. Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device. Sci Rep. 2016 Feb;15(6):21061.
   Google Scholar
• Hoffmann OI, Ilmberger C, Magosch S, et al. Impact of the spheroid model complexity on drug response. J Biotechnol. 2015 Jul 10;205:14–23.
   PubMed Web of Science ®Google Scholar
• Theodoraki MA, Rezende CO Jr., Chantarasriwong O, et al. Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening. Oncotarget. 2015 Aug 28;6(25):21255–21267.
   PubMedGoogle Scholar
• Hwang H, Kim EK, Park J, et al. RhoA and Rac1 play independent roles in lysophosphatidic acid-induced ovarian cancer chemotaxis. Integr Biol (Camb). 2014 Mar;6(3):267–276.
   PubMed Web of Science ®Google Scholar
• Olivo C, Vanni C, Mancini P, et al. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells. Oncogene. 2000 Mar 9;19(11):1428–1436.
   PubMed Web of Science ®Google Scholar
• Su S, Li Y, Luo Y, et al. Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. Oncogene. 2009 Aug 27;28(34):3047–3057.
   PubMed Web of Science ®Google Scholar
• Kim EK, Park JM, Lim S, et al. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells. J Biol Chem. 2011 Jul 8;286(27):24036–24045.
   PubMed Web of Science ®Google Scholar
• Tkach V, Bock E, Berezin V. The role of RhoA in the regulation of cell morphology and motility. Cell Motil Cytoskeleton. 2005 May;61(1):21–33.
   PubMed Web of Science ®Google Scholar
• Guo F, Zheng Y. Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts. Mol Cell Biol. 2004 Feb;24(3):1426–1438.
   PubMed Web of Science ®Google Scholar
• Hirakawa M, Oike M, Karashima Y, et al. Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium. J Physiol London. 2004 Jul 15;558(2):479–488.
   Google Scholar
• Appert-Collin A, Bennasroune A, Jeannesson P, et al. Role of LRP-1 in cancer cell migration in 3-dimensional collagen matrix. Cell Adh Migr. 2017 Jul 4;11(4):316–326.
   PubMed Web of Science ®Google Scholar